A Win For Immuron Limited

Fri, Sep 04, 2026 at 07:37 PM

Immuron Limited (IMRN:NASDAQ) rocketted at $1.8, a gain of 62.2%. On Fri, Sep 04, 2026, IMRN:NASDAQ touched a New 2-Week High of $1.8. The stock appeared on our News Catalysts scanner on Fri, Sep 04, 2026 at 12:28 PM in the 'MISCELLANEOUS' category. From Fri, Aug 21, 2026, the stock recorded 40.00% Up Days and 27.27% Green Days

About Immuron Limited (IMRN:NASDAQ)

Immuron Ltd is a biopharmaceutical company which develops polyclonal antibodies for the treatment and prevention of diseases. It products include Travelan, IMM-124E for NASH and IMM-529 for Clostridium difficile infection.

Top 10 Gainers:

Vestand Inc Cl A (New) (VSTD:NASDAQ), 333.33%
Hempacco Co., Inc. (HPCO:NASDAQ), 100%
Immuron Limited (IMRN:NASDAQ), 62.16%
CDT Environmental Technology Investment Holdings Limited (CDTG:NASDAQ), 46.72%
American Outdoor Brands, Inc. (AOUT:NASDAQ), 44.66%
Onconetix, Inc. (ONCO:NASDAQ), 38.02%
NeuroSense Therapeutics Ltd. (NRSN:NASDAQ), 27.19%
GRI Bio, Inc. (GRI:NASDAQ), 25.76%
Mannatech, Incorporated (MTEX:NASDAQ), 23.46%
Nature Wood Group Limited (NWGL:NASDAQ), 23.3%